Video

Access to PCSK9 Inhibitors Remains a Challenge

Author(s):

Lauren Santye, Assistant Editor

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses challenges in gaining access to cholesterol-lowering PCSK9 inhibitors.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses challenges in gaining access to cholesterol-lowering PCSK9 inhibitors.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image Credit: shidlovski | stock.adobe.com
Related Content
Atopic dermatitis. Red, itchy hands with blisters seen by a dermatologist
September 14th 2025

Amlitelimab Meaningfully Clears Skin in Moderate-to-Severe Atopic Dermatitis

Luke Halpern, Assistant Editor
Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage
September 14th 2025

Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage

Jennifer Griffin, PharmD, MS Luke Halpern, Assistant Editor
Pharmacist Spotlight: Luke Witkowski, PharmD
September 14th 2025

Pharmacist Spotlight: Luke Witkowski, PharmD

PT Staff Luke Witkowski, PharmD
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
September 14th 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Illustration from research for genomic medicine or gene therapy.
September 14th 2025

Navigating the Complex Landscape of Sickle Cell Gene Therapy: Operational Challenges and Collaborative Solutions

Luke Halpern, Assistant Editor
Neuromuscular disorders neon glow nervous system visualizing diseases like ALS myasthenia gravis being treated advanced therapies under Neurology
September 14th 2025

Cemdisiran Monotherapy Improves Activities of Daily Living in Myasthenia Gravis

Luke Halpern, Assistant Editor
© 2025 MJH Life Sciences

All rights reserved.